×
Want to know more about the Kunena Project? See how the open source philosophy drives our community, follow our development on GitHub, and how you can participate to make Kunena even better.
bestcialis20mg.com
- brand name cialis online Comments for the FDA s March 24 25, 2021 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Regarding Biologics License Application for the Osteoarthritis Drug Tanezumab HRG Publication 2570 Public Citizen urges the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to recommend that the Food and Drug Administration FDA not approve the biologics license application for tanezumab because the totality of the evidence from three published pivotal phase 3 randomized clinical trials demonstrates that the drug fails to provide clinically meaningful benefit but does dramatically increase the rates of rapidly progressive osteoarthritis and other types of serious joint damage and of total joint replacements in a dose and duration dependent manner
